Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News on Pharma

4 Biotech Stocks Seeing Explosive Momentum Gains

A wider range of stocks have been gaining traction lately as major indexes push toward record highs. The SPDR SP Biotech ETF (NYSE:XBI) is up more than 40% over the past six months and is on the verge of breaking out. Here's a look at several momentum standouts in the…

Benzinga

AMD's OpenAI Deal Could Spark A New AI Arms Race With Nvidia

Advanced Micro Devices Inc.’s (NASDAQ:AMD) multi-year deal with OpenAI could unlock $135 billion in revenue and mount a serious challenge to Nvidia Corp.’s (NASDAQ:NVDA) long-standing dominance, according to Goldman Sachs.

Benzinga

EXCLUSIVE: Envoy Medical Cuts Capital Needs After FDA Approval For Final Trial Stage Of Cochlear Implant Trial

Envoy Medical Inc. (NASDAQ:COCH) announced on Tuesday that it has received U.S. Food and Drug Administration (FDA) approval to expand its pivotal clinical trial for the fully implanted Acclaim cochlear implant to the final stage, based on promising three-month data from the first 10 patients.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

$68 million COVID-era federal funding loss and other potential cuts threaten Texas opioid fight

In addition to the cuts, local nonprofits are also having problems accessing federal help for opioid reversal medication, such as Narcan.

The Texas Tribune

Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket

Shares of Telomir Pharmaceuticals Inc (NASDAQ:TELO) rose sharply in pre-market trading after the company released promising preclinical study results for its lead compound, Telomir-1.

Benzinga

Famed Short-Seller Jim Chanos Questions AMD's Revenue Forecast Following OpenAI Deal: 'Shouldn't This Deal Bring In More… For $AMD?'

Renowned short-seller Jim Chanos has publicly questioned the financial benefits of the landmark partnership between Advanced Micro Devices Inc. (NASDAQ:AMD) and OpenAI, suggesting the deal may not be as lucrative for AMD as it appears.

Benzinga

Options Corner: Despite Political Woes, Kenvue Can Still Make Tylenol Great Again

Amid a contentious political environment, consumer pharmaceutical firm Kenvue Inc (NYSE:KVUE) finds itself under a harsh spotlight. Specifically, its popular drug Tylenol has attracted the ire of the White House. Late last month, President Donald Trump stated on Truth Social that pregnant women shouldn't use Tylenol unless absolutely necessary. With…

Benzinga

Read news from The Economist, FT, and more,
with one subscription

AngioDynamics Eyes Growth Despite Tariffs

AngioDynamics, Inc. (NASDAQ:ANGO) posted stronger-than-expected first-quarter results across its Med-Tech businesses and lifted its fiscal 2026 guidance.

Benzinga

Teladoc (TDOC) Shares Climb On Bullish Commentary From Citron Research

Shares of Teladoc Health Inc (NYSE:TDOC) are surging Friday morning after Citron Research posted bullish comments on the telehealth provider, asserting they were “not wrong, just early” on the stock’s potential. The commentary sparked renewed investor interest, pushing the stock higher in early trading.

Benzinga

Anti-abortion groups furious as FDA approves generic abortion pill

Abortion rights supporters hail win for evidence-backed medicine as Evita Solutions’ generic version of mifepristone given approval

The Guardian - US

The Best Biotech ETFs to Buy

Biotech ETFs offer investors exposure to the most innovative and growth-oriented industry within the traditionally defensive healthcare sector.

Kiplinger

These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap

Health care stocks are on track for their best week in years, yet even after the rally, several pharma giants remain absurdly cheap by market standards.

Benzinga

Why Concorde International Group Shares Are Trading Higher By 55%; Here Are 20 Stocks Moving Premarket

Shares of Concorde International Group Ltd. (NASDAQ:CIGL) rose sharply in pre-market trading as the company revealed that its Board of Directors and Compensation Committee had approved a 2025 Equity Incentive Plan earlier that day.

Benzinga

Trump-Pfizer Deal Pushes Health Care Stocks To Best Rally In 5 Years

Investors cheered a breakthrough drug pricing agreement between President Donald Trump and Pfizer Inc. (NYSE:PFE), sparking a sector-wide surge in health care stocks that delivered the biggest rally in five years.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Axios

Inside the TrumpRx website and its unusual launch

Trump has been urging prescription drug manufacturers to lower U.S. prices.

Benzinga

Moderna Stock Is Rallying Wednesday: What's Driving The Action?

Moderna Inc (NASDAQ:MRNA) stock is trading higher Wednesday afternoon, lifted by positive sentiment across the pharmaceutical sector. The rally follows a landmark agreement Tuesday between Pfizer Inc (NYSE:PFE) and the Trump administration to lower prescription drug prices.

Benzinga

Pfizer's TrumpRx Pact Sends Shockwaves: Why UnitedHealth, Lilly And CVS Can't Look Away

Pfizer Inc's (NYSE:PFE) deal with Washington isn't just a handshake in the Oval Office — it's a seismic jolt to America's drug-pricing game. By agreeing to sell medicines on the government's new TrumpRx platform at steep discounts and extend "most favored nation" (MFN) pricing to Medicaid, Pfizer bought itself a…

The Guardian - UK

Big pharma is at war with the UK, and the government can’t back down now

The industry has always wanted the NHS to pay more for its drugs; now it is pulling research and investment out of Britain, says director of Global Justice Now Nick Dearden

Get all your
news in one place.

100’s of premium titles.
One news app.

Evening Standard

Baroness Michelle Mone-linked company loses £122m High Court battle with government over faulty PPE

Michelle Mone’s husband Douglas Barrowman branded the PPE Medpro defeat in the High Court a “whitewash”

Evening Standard

Convatec to open new R&D hub in Manchester as part of £500m UK investment

The medical products firm said the ‘flagship’ site would open in 2027.

International Business Times UK

TrumpRx: Trump and Pfizer Announce Landmark Deal to Slash US Drug Prices by Up to 85%

TrumpRx will slash US drug prices by up to 85% under a new deal with Pfizer, bringing costs in line with other nations and boosting US investment.

Caixin Global

Beijing Life Science Hub Aims to Accelerate Drug Innovation

Zhongguancun Life Science Park is fostering a full-chain ecosystem to shorten drug development cycles

International Business Times

Trump Announces Pfizer Deal He Says Will Lower Certain Drug Prices

The Trump administration on Tuesday announced a deal granting Pfizer a three-year reprieve on planned tariffs as the pharmaceutical giant vowed to voluntarily lower the prices of unspecified drugs for US purchase.

Benzinga

Pfizer Becomes First Drugmaker To Join Trump's Price Cut Push

On Tuesday, Pfizer Inc. (NYSE:PFE) announced a historic agreement with the Trump Administration to ensure U.S. patients pay lower prices for their prescription medicines.

Benzinga

AnaptysBio Charts Path To Split Into Two Public Companies By 2026

AnaptysBio, Inc. (NASDAQ:ANAB) announced on Tuesday that it plans to explore separating its business into two independent, publicly traded companies.

1 … 6 7 8 9

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the Trump Administration

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.